Management of benign oesophageal strictures
- PMID: 31205660
- PMCID: PMC6540277
- DOI: 10.1136/flgastro-2018-101075
Management of benign oesophageal strictures
Abstract
Benign oesophageal strictures are an important gastrointestinal condition that can cause substantial morbidity. There are many different aetiologies and each case needs careful evaluation and individualised treatment. Management usually involves targeting therapy to the underlying cause, but oesophageal dilatation is an important part of the algorithm. The recent British Society of Gastroenterology guidelines provide advice on the use of dilatation for benign strictures and cover patient preparation, the dilatation procedure and disease-specific considerations. This article provides a summary of the key messages from the guidelines and applies them to routine clinical practice. It also includes practical advice on the clinical assessment, investigation and management of benign oesophageal strictures and gives an approach to the management of refractory strictures. Areas where evidence is sparse and further research is needed are highlighted.
Keywords: gastroesophageal reflux disease; oesophageal strictures; therapeutic endoscopy.
Conflict of interest statement
Competing interests: SE has received honoraria from Olympus/Keymed and sponsorship from FALK to attend international meetings.
References
-
- Richter JE. Long-term management of gastroesophageal reflux disease and its complications. Am J Gastroenterol 1997;92:30S–4. - PubMed
-
- Mellow MH, Pinkas H. Endoscopic laser therapy for malignancies affecting the esophagus and gastroesophageal junction. Analysis of technical and functional efficacy. Arch Intern Med 1985;145:1443–6. - PubMed
LinkOut - more resources
Full Text Sources